Wissenschaftliche Arbeiten

Uzm. Dr. Meryem Şener

26 Publikationen. Neben jeder Publikation steht die Quelle der Angabe.

Zurück zum Profil

  1. Olgular Eşliğinde Erişkin Hematoloji

    Akademisyen Kitabevi eBooks, 2026

    DOI 10.37609/akya.4308 Frei zugänglicher VolltextQuelle: OpenAlex

  2. Long-Term Treatment Outcomes and Prognostic Factors in Patients with Chronic Myeloid Leukemia: A 24-Year Single-Center Retrospective Study

    Medicina, 2026

    DOI 10.3390/medicina62112150 Frei zugänglicher VolltextQuelle: ORCID

  3. Factors Affecting Time to First Treatment in Early-Stage Chronic Lymphocytic Leukemia: A Single-Center Retrospective Cohort Study

    Diagnostics, 2026

    DOI 10.3390/diagnostics16213532 Frei zugänglicher VolltextQuelle: ORCID

  4. Treatment Patterns, Treatment Response, and Survival Outcomes in Patients with Multiple Myeloma: A Single-Center Real-World Study

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15218340 Frei zugänglicher VolltextQuelle: ORCID

  5. Esansiyel Trombositemiden Sekonder Myelofibroza Dönüşüm: Genç Bir Olgu

    Akademisyen Kitabevi eBooks, 2026

    DOI 10.37609/akya.4308.c19912 Quelle: ORCID

  6. Diagnostic Concordance and Superiority of Flow Cytometry Over Immunohistochemistry in Acute Leukemia Immunophenotyping: A Single-Center Study

    Medical Science Monitor, 2026

    DOI 10.12659/msm.952903 PMID 42563366 Frei zugänglicher VolltextQuelle: OpenAlex

  7. Effects of ferric carboxymaltose on hypophosphatemia in patients with iron deficiency anemia: A single-center retrospective study

    Medicine Science | International Medical Journal, 2026

    DOI 10.5455/medscience.2026.01.09 Frei zugänglicher VolltextQuelle: OpenAlex

  8. TREATMENT MANAGEMENT IN MULTIPLE MYELOMA WITH RENAL DISORDER

    Hematology, Transfusion and Cell Therapy, 2025

    DOI 10.1016/j.htct.2025.103905 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: ORCID

  9. EZH-2 expression and prognostic significance in patients with low-grade non-Hodgkin lymphoma

    Scientific Reports, 2025

    DOI 10.1038/s41598-025-04394-6 PMID 40456891 Frei zugänglicher VolltextQuelle: ORCID

  10. Immune and Inflammation Markers as a Predictor of Overall Survival in Patients with Hematologic Malignancies: A Retrospective Cohort Study

    Medicina, 2025

    DOI 10.3390/medicina61061019 PMID 40572707 17 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  11. Current view on the etiopathogenesis of aplastic anemia

    Korean Journal of Physiology and Pharmacology, 2025

    DOI 10.4196/kjpp.24.214 PMID 40288994 2 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  12. POSTER: CLL-340 Prognostic Significance of Neutrophil and Monocyte Counts in Chronic Lymphocytic Leukemia (CLL)

    Clinical Lymphoma Myeloma & Leukemia, 2025

    DOI 10.1016/s2152-2650(25)00668-8 Quelle: OpenAlex

  13. CLL-340: Prognostic Significance of Neutrophil and Monocyte Counts in Chronic Lymphocytic Leukemia (CLL)

    Clinical Lymphoma Myeloma & Leukemia, 2025

    DOI 10.1016/s2152-2650(25)01846-4 Quelle: OpenAlex

  14. A retrospective cross-sectional study to investigate femoral head avascular necrosis in sickle cell disease in Türkiye

    Blood, 2025

    DOI 10.1182/blood-2025-1162 Frei zugänglicher VolltextQuelle: OpenAlex

  15. CHRONİC LYMPHOCYTIC LEUKEMIA (CLL): IMMUNOGENETICS AND DIAGNOSIS

    Hematology Transfusion and Cell Therapy, 2025

    DOI 10.1016/j.htct.2025.106209 Frei zugänglicher VolltextQuelle: OpenAlex

  16. CLINICAL CHARACTERISTICS AND TREATMENT OUTCOMES IN ADULT ITP PATIENTS: A SINGLE-CENTER EXPERIENCE

    Hematology Transfusion and Cell Therapy, 2025

    DOI 10.1016/j.htct.2025.106129 Frei zugänglicher VolltextQuelle: OpenAlex

  17. A Case of Multiple Myeloma with Atypical Cutaneous Presentation Treated by Daratumumab + CYBORG

    Hematology, Transfusion and Cell Therapy, 2024

    DOI 10.1016/j.htct.2024.04.017 Frei zugänglicher VolltextQuelle: ORCID

  18. A Rare Intersection: Case Study on Sickle-Cell Thalassemia and Lymphoma

    Hematology, Transfusion and Cell Therapy, 2024

    DOI 10.1016/j.htct.2024.04.019 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: ORCID

  19. Essential Thrombocythemia Complicated by Addison's Disease: A Case of Overlapping Endocrine and Hematological Disorders

    Hematology, Transfusion and Cell Therapy, 2024

    DOI 10.1016/j.htct.2024.04.018 Frei zugänglicher VolltextQuelle: ORCID

  20. Allojenik Kemik İliği Nakli İle Tedavi Edilen Langerhans Hücreli Histiyositoz Olgusu

    Akademisyen Kitabevi eBooks, 2024

    DOI 10.37609/akya.2870.c11273 Quelle: ORCID

  21. Pansitopeni ve Organomegali ile Gelen Hastada Visseral Leishmania Olgusu

    Akademisyen Kitabevi eBooks, 2024

    DOI 10.37609/akya.2870.c11285 Quelle: ORCID

  22. Vakalarla Hematoloji

    Akademisyen Kitabevi eBooks, 2024

    DOI 10.37609/akya.2870 Frei zugänglicher VolltextQuelle: ORCID

  23. Peripheral T-cell Lymphoma with Jaundice: Insights from a Complex Case

    Hematology Transfusion and Cell Therapy, 2024

    DOI 10.1016/j.htct.2024.04.020 Frei zugänglicher VolltextQuelle: OpenAlex

  24. From Diagnosis to Recovery: Addressing Rare Malaria with Travel History Using Standard and Apheresis Therapies

    Hematology Transfusion and Cell Therapy, 2024

    DOI 10.1016/j.htct.2024.04.047 Frei zugänglicher VolltextQuelle: OpenAlex

  25. Challenging the Presentation Paradigm in DLBCL: A Case Study of Extraordinary Disease Distribution

    Hematology Transfusion and Cell Therapy, 2024

    DOI 10.1016/j.htct.2024.04.046 Frei zugänglicher VolltextQuelle: OpenAlex

  26. EZH2 expression and its prognostic significance in patients with low - grade non-hodgkin lymphoma.

    Çukurova University Institutional Repository, 2019

    Frei zugänglicher VolltextQuelle: OpenAlex